top of page
Organoid%20with%20TILs_edited.jpg

Research Interest

"Improving Colorectal Cancer Outcomes Through Research and Innovation"

20201231_100536_edited.jpg

Robotic Surgery and Artificial Intelligence

The future is now, increasing surgical precision, tailored individual approach, increasing diagnostic accuracy and a quicker return to baseline quality of life.

Statistics logo.png

Biostatistics in Colorectal Cancer Outcomes

Ensuring all treatment pathways from first consultation, multidisciplinary interactions, technological advances in both surgery and chemotherapeutic agents, post-operative recovery and long-term follow-up are continously being evaluated with most up-to-date scientific literature including new discoveries made from our laboratory.

Joe%202236_%5B47847%2C12367%5D_composite

Translational Research

A team of highly motivated laboratory and clinician scientists working together to identify mechanistic pathway(s) for cancer resistance and new therapeutic drugs that can potentially improve a patient's response to treatment and thus their cancer outcomes.

Publications

To accesss some of Dr Joseph Kong's publications on robotic surgery, colorectal cancer outcomes, peritoneal malignancies and translational research, please visit Research Gate by clicking on this link

  1. Immune Mediated Colitis: A Surgical Perspective. Le KDR, Choy KT, Roth S, Heriot AG, Kong JCH, ANZ Journal of Surgery April 2023 (in press)

  2. Robotic versus Laparoscopic Proctectomy: A Comparative Study of Short-term Economic and Clinical Outcomes. Larach JT, Flynn J, Tew M, Fernando D, Apte S, Mohan H, Kong JCH, McCormick JJ, Warrier SK, Heriot AG, International Journal of Colorectal Disease March 2023 (in press)

  3. Intensification of Local Therapy with High Dose Rate, Intraoperative Radiation Therapy (HDR-IORT) and Extended Resection for Locally Advanced and Recurrent Colorectal Cancer. Agas RA, Tan J, Xie J, Van Dyk S, Kong JCH, Heriot AG, Ngan S, Clinical Colorectal Cancer March 2023 (in press)

  4. Impact of Neoadjuvant Systemic Chemotherapy Followed by Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy for Appendiceal Adenocarcinoma. Flood M, Roberts G, Mitchell C, Ramsay R, Michael M, Heriot AG, Kong JCH, Asia-Pacific Journal of Clinical Oncology March 2023 (in press)

  5. Impact of the Approach on Conversion to Open Surgery During Minimally Invasive Restorative Total Mesorectal Excision for Rectal Cancer. Larach JT, Kong JCH, Flynn J, Wright T, Mohan H, Waters PS, McCormick J, Warrier S, Heriot AG, International Journal of Colorectal Disease March 2023 (in press)

  6. The Impact of Peri-operative Enteral Immunonutrition on Post-operative Complications in Gastrointestinal Cancer Surgery: A Meta-analysis. Khan A, Wong J, Riedel B, Laing E, Beaumont A, Kong JCH, Warrier S, Heriot AG, Annals of Surgical Oncology Feb 2023 (in press)

  7. Robotic Pelvic Side-wall Lymph Node Dissection for Rectal Cancer: A Systematic Review of Videos and Application of the IDEAL 2A Framework. Mansour K, Mohan H, Jiang W, Waters OS, Larach JT, Apte SS, Kong JCH, Heriot AG, Warrier S, Journal of Robotic Surgery Jan 2023 (in press)

  8. Immunotherapy in Colorectal Cancer: A Beacon of Hope. Mui M, Kong JCH, Guerra, G, Behrenbruch C, Michael M, Heriot AG, ANZ Journal of Surgery Jan 2023 (in press)

  9. The Management of Clinically Suspicious Para-aortic Lymph Node Metastasis in Colorectal Cancer: A Systematic Review. Chen MZ, Tay YK, Prabhakaran S, Kong JCH, Asia-Pacific Journal of Clinical Oncology Jan 2023 (in press)

  10. Appendiceal Pseudomyxoma Peritonei: Unmasking the Indolent Invader. Jain A, Flood M, Ramsay R, Michael M, Kong JCH, Heriot AG, ANZ Journal of Surgery Dec 2022 (in press)

  11. Individualised Chemotherapy and Immunotherapy for Rectal Cancer: The Next Step Forward. Prabhakaran S, Kong JCH, ANZ Journal of Surgery Dec 2022 (in press)

  12. Anastomotic Leak in Colorectal Surgery: Predictive Factors and Survival. Prabhakaran S, Prabhakaran S, Lim WM, Guerra G, Heriot A, Kong JCH, Polish Journal of Surgery Dec 2022 (in press)

  13. Sarcopenia: the “hidden” marker of surgical outcome. Wong J, Khan A, Kong JCH, Heriot AG, ANZ Journal of Surgery Dec 2022 (in press)

  14. Elective Surgery System Strengthening: Development, Measurement, and Validation of the Surgical Preparedness Index Across 1632 Hospitals in 119 Countries. NIHR Global Health Unit on Global Surgery; COVIDSurg Collaborative, Lancet 2022 Nov 5;400(10363):1607-1617

  15. The Management of Peri-operative Anaemia in Patients Undergoing Major Abdominal Surgery in Australia and New Zealand: A Prospective Cohort Study. The POSTVenTT Study Collaborative, The Medical Journal of Australia Sep 2022 (in press)

  16. Operative and Oncological Outcomes after Robotic Rectal Resection Compared to Laparoscopy: A Systematic Review and Meta-analysis. Flynn J, Larach T, Kong JCH, Rahme J, Waters P, Warrier SK, Heriot AG, ANZ Journal of Surgery Sep 2022 (in press)

  17. The Utility of ctDNA in Colorectal Cancer with Peritoneal Metastases. Prabhakaran S, Xue J, Prabhakaran S, Lim WM, Guerra G, Heriot AG, Kong JCH, ANZ Journal of Surgery Sep 2022 (in press)

  18. Retrospective Audit: Utility of PET Scan in Routine Preoperative Rectal Cancer Staging. Chen M, Zhang X, Mui M, Kong JCH, Heriot AG, Ellis-Clark J, ANZ Journal of Surgery Aug 2022 (in press)

  19. Application of Minimally Invasive Approaches to Pelvic Exenteration for Locally Advanced and Locally Recurrent Pelvic Malignancy – A Narrative Review of Outcomes In An Evolving Field. Casey L, Larach JT, Waters PS, Kong JCH, McCormick JJ, Heriot AG, Warrier SK, European Journal of Surgical Oncology Aug 2022 (in press)

  20. Metabolic and Magnetic Resonance Imaging – Complementary Modalities for the Preoperative Assessment of Lateral Pelvic Lymph Nodes in Rectal Cancer.* Cribb B,* Kong JCH, Kay JS, Tan TH, Noe G, Gest B, Lee A, Oon S, Warrier S, Heriot AG, ANZ Journal of Surgery Aug 2022 (in press) * Co-first author and has contributed equally to this study

  21. Patient-Related Functional Outcomes After Robotic Assisted Rectal Surgery Compared to a Laparoscopic Approach: A Systematic Review and Meta-analysis. Flynn J, Larach T, Kong JCH, Waters P, McCormick JJ, Warrier SK, Heriot AG, Disease of Colon and Rectum July 2022 (in press)

  22. Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial. Sampurno S, Chittleborough T, Dean M, Michael F, Carpinteri S, Millen RM, Cain H, Kong JCH, Mackay J, Warrier SK, McCormick J, Hiller JG, Heriot AG, Ramsay RG, Lynch AC, Annals of Surgical Oncology July 2022 (in press)

  23. Exercise and Colorectal Cancer Survival: An Updated Systematic Review and Meta-analysis. Choy KT, Lam K, Kong JCH, International Journal of Colorectal Disease July 2022 (in press)

  24. Total neoadjuvant therapy (TNT) in rectal cancer: To or Not To Give? Mui M, Kong JCH, Ramsay R, Michael M, Heriot AG, ANZ Journal of Surgery July 2022 (in press)

  25. Robotic Colon Surgery in Obese Patients: A Systematic Review and Meta-analysis. Wang J, Johnson NW, Casey L, Carne P, Bell S, Chin M, Simpson S, Kong JCH, ANZ Journal of Surgery May 2022 (in press)

  26. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases in an Elderly Population: Outcomes from a Single Centre. Flood M, Narasimhan V, Waters PS, Kong JCH, Ramsay R, Michael M, Tie J, McCormick JJ, Warrier SK, Heriot AG, ANZ Journal of Surgery May 2022 (in press)

  27. Treatment Strategies for Locally Recurrent Rectal Cancer. Wang J, Prabhakaran S, Larach T, Warrier SK, Bednarski BK, Ngan SY, Leong T, Rodriguez-Bigas M, Peacock O, Chang G, Heriot AG, Kong JCH. European Journal of Surgical Oncology May 2022 (Accepted)

  28. The National Aeronautics and Space Administration – Task Load Index: NSA-TLX – Evaluation of its use in surgery. Bell SW, Kong JCH, Clark D, Carne P, Skinner S, Pillinger S, Burton P, Brown W. ANZ Journal of Surgery May 2022 (Accepted)

  29. The Complication Profile of Low Hartmann’s in Rectal Cancer: A Systematic Review and Meta-analysis. KT Choy, J Lee, S Prabhakaran, P Waters, AG Heriot, SK Warrier, JCH Kong. ANZ Journal of Surgery May 2022 (Accepted)

  30. The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis. Flood MP, Kong JCH, Wilson K, Mohan H, Waters PS, McCormick JJ, Warrier SK, Tie J, Ramsay R, Michael M, Heriot AG. Annals of Surgical Oncology March 2022 (Accepted)

  31. Melbourne Colorectal Collaboration: A Multicentre Review of the Impact of COVID-19 on Colorectal Cancer in Melbourne, Australia. Melbourne Colorectal Collaboration. ANZ Journal of Surgery March 2022 (Accepted)

  32. Robotic Beyond Total Mesorectal Excision Surgery for Primary and Recurrent Pelvic Malignancy: Feasibility, Safety and Short-Term Outcomes. Larach T, Flynn J, Fernando D, Mohan H, Rajkomar A, Waters P, Kong JCH, McCormick J, Heriot A, Warrier S. Colorectal Disease March 2022 (in press)

  33. Latest Evidence on the Management of Early-stage and Locally Advanced Rectal Cancer: A Narrative Review. Prabhakaran S, Yang TWW, Johnson N, Bell S, Chin M, Simpson P, Carne P, Farmer KC, Skinner S, Warrier S, Kong JCH. ANZ Journal of Surgery Jan 2022 (Accepted)

  34. Diagnostic Performance of Positron Emission Tomography in the Staging of Pseudomyxoma Peritonei. Flood M, Kong JCH, Pham T, Waters PS, Ramsay R, Michael M, McCormick JJ, Warrier S, Akhurst T, Heriot A. European Journal of Surgical Oncology 2022 (Accepted)

  35. Lateral Pelvic Sidewall Dissection in Rectal Cancer: How Can Emerging Colorectal Surgeons Prepare for Changing Practice? Lokuhetty N, Mohan H, Kong JCH, Heriot AG, Warrier SK. British Journal of Surgery 2021 (Accepted)

  36. Functional Outcomes After Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A Systematic Review and Meta-analysis. Cribb B, Kong JCH, McCormick J, Warrier SK, Heriot AG. International Journal of Colorectal Disease 2021 (Accepted)

  37. No stone left unturned: A case malignant mimicry. Gearing PF, Apte S, Cohen L, Mohan H, Heriot AG, Kong JCH, Waters P. ANZ Journal of surgery 2021 (Accepted)

  38. Surgical Quality in Colorectal Anastomosis – the time is overdue in the assessment of anastomotic integrity. Warrier SK, Williams E, Prabhakaran S, Farmer KC, Kong JCH. ANZ Journal of Surgery 2021 (Accepted)

  39. Metastatic gastrointestinal stromal tumour of the descending colon; the importance of complete histological assessment prior to operative management. Casey L, Stokes M, Puckett J, Kong JC, Skinner S. ANZ Journal of Surgery 2021 (Accepted)

  40. Meta-analysis and Systematic Review in Patients with Locally Advanced Rectal Cancer with Total Mesorectal Excision (TME) alone and TME combined with Extended Pelvic Lymph Node Dissection after Neoadjuvant Chemoradiotherapy. Kong JC, Cribb BI, Mui M, Prabhakaran S, Wang J, Guerra GR, Warrier SK, Heriot AG. Indian Journal of Surgery 2021 (Accepted)

  41. Robotic Total Mesorectal Excision (TME) or Transanal Total Mesorectal Excision (TaTME) Meta-analysis. Chen M, Tay YK, Warrier SK, Heriot AG, Kong JC. ANZ Journal of Surgery 2021 (Accepted)

  42. Comparison of Colorectal Cancer Outcomes in Young Adults and Octogenarians. Prabhakaran S,* Kong JCH,* Bell S, Warrier S, Simpson P, Chin M, Skinner S, Carne P. American Journal of Surgery 2021 (Accepted)      * Co-first author and has contributed equally to this study

  43. Is Neoadjuvant Therapy an Alternative Strategy to Immediate Surgery in Locally Perforated Colon Cancer? Kong JC, Lee J, Gosavi R, Ngan SY, Tillman MM, Bednarski BK, Heriot AG, Chang GJ, Warrier SK. Colorectal Disease 2021 (Accepted)

  44. The Predictive Value of PET/CT for Distant Recurrences in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Kong JC, Ryan J, Akhurst T, Ngan SY, Michael M, Tie J, Warrier SK, Heriot AG. Journal of Medical Imaging and Radiation Oncology 2021 (Accepted)

  45. Does Adding Neoadjuvant Check-point Inhibitor in High Risk Locally Advanced Rectal Cancer Increase Tumour Response? Kong JC, Waters P, Warrier SK, Heriot AG. ANZ Journal of Surgery 2021 (Accepted)

  46. The Learning Curve in Robotic Colorectal Surgery Compared to Laparoscopic Colorectal Surgery: A Systematic Review. Flynn J, Larach T, Kong JC, Waters P, Warrier SK, Heriot A. Colorectal Disease 2021 (Accepted)

  47. Reply to: Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not. Kong JC, Ngan S, Tie J, Heriot A. Annals of Surgical Oncology 2021 (Accepted)

  48. Predictive Factors for Distant Recurrence of Colorectal Cancer in Patients after Curative Resection of Stage I-III Colorectal Cancer in Australia. Kong JC, Prabhakaran S, Chin M, Carne P, Farmer C, Skinner S, Warrier SK, Bell S. Langenback’s Archieves of Surgery 2021 (Accepted)

  49. The Impact of the COVID-19 Pandemic on Colorectal Cancer Diagnosis and Management: A Binational Colorectal Cancer Audit Study. Williams E, Kong JC, Singh P, Prabhakaran S, Warrier SK, Bell S. ANZ Journal of Surgery 2021 (accepted)

  50. Predicting Difficult Laparoscopic Total Mesorectal Excision Using the BCCA Registry. Kong JC, Praphakaran S, Fraser A, Warrier S, Heriot AG. Polish Journal of Surgery 2021 (Accepted)

  51. Appendiceal Pseudomyxoma Peritonei: Predictors of Recurrence and Iterative Surgery. Kong JC, Flood MP, Guerra GR, Liesegang A, Wong WJ, Mitchell C, Warrier SK, Naidu S, Meade B, Lutton N, Heriot AG. Colorectal Disease 2021 (Accepted)

  52. Molecular and Genomic Characterisation of a Panel of Human Anal Cancer Cell Lines. Guerra G, Kong J, Millen R, Read M, Liu D, Sampurno S, Sia J, Bernardi MP, Chittleborough T, Behrenbruch C, Teh J, Xu H, Haynes N, Yu Jiaan, Lupat R, Hawkes D, Di Costanzo N, Tothill R, Mitchell C, Ngan S, Heriot A, Ramsay R, Phillips W. Cell Death and Disease 2021 (Accepted)

  53. Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer: A Systematic Review and Meta-analysis. Chia C, Gosavi R, Michael M, Heriot AG, Warrier SK, Kong J. International Journal of Colorectal Disease 2021 (Accepted)

  54. Robotic Complete Mesocolic Excision versus Conventional Robotic Right colectomy for Right-sided Colon Cancer: A Comparative Study of Perioperative Outcomes. Larach T, Flynn J, Wright T, Rajkomar AKS, McCormic JJ, Kong JC, Smart PJ, Heriot AG, Warrier SK. Surgical Endoscopy 2021 (Accepted)

  55. Meta-analysis of Direct Surgery Lateral Pelvic Node Dissection for Rectal Cancer. *Cribb B, *Kong JC, McCormick J, Warrier SK, Heriot AG. Colorectal Disease 2021 (Accepted) * Co-first author and has contributed equally to this study

  56. Synchronous Liver Resection, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis. Flood M, Das A, Soucisse M, Kong JC, Ramsay R, Michael M, Loveday B, Warrier S, Heriot AG. Diseases of Colon and Rectum 2021 Mar, doi: 10.1097/DCR.0000000000002027 (online ahead of print)

  57. Robotic versus Laparoscopic Ventral Mesh Rectopexy: A Systematic Review and Meta-analysis. Flynn J, Larach T, JC Kong, Warrier SK, Heriot AG. International Journal of Colorectal Disease 2021 Mar, doi: 10.1007/s00384-021-03904-y (online ahead of print)

  58. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis of Oncological and Operative Outcomes. Kong JC, Soucisse M, Michael M, Tie J, Ngan SY, Leong T, McCormick J, Warrier SK, Heriot AG. Annals of Surgical Oncology 2021 (Accepted)

  59. Apples and Oranges: The Evidence Regarding Lateral Pelvic Lymph Node Dissection for Rectal Cancer. Kong CH, Chang G. Surgery 2021 Mar 18;S0039-6060(21)00139-2

  60. Robotic External Iliac, Deep Inguinal and Obturator Lymph Node Dissection for Stage III Melanoma – A Video Vignette. Kong CH, Fisher SB, Bednarski BK. Colorectal Disease 2021 Feb, doi: 10.1111/codi.15570 

  61. Does Rectal Tube Placement After an Anterior Resection for Rectal Cancer Reduce Anastomotic Leak? A Systematic Review and Meta-analysis. Choy KT, Yang W, Heriot A, Warrier SK, Kong JCH. International Journal of Colorectal Disease 2021 Jan, doi: 10.1007/s00384-021-03851-8

  62. Masquerading Mucinous Metastases – Cutaneous Colorectal Cancer Metastasis of the Toe. Larkins KM, Heriot A, Warrier SK, Kong JC. ANZ Journal of Surgery 2021 Feb, doi: 10.1111/ans.16660 

  63. Comparing functional outcomes between Transanal Total Mesorectal Excision (TaTME) and Laparoscopic Total Mesorectal Excision (LaTME) for rectal cancer: A systematic review and meta-analysis. Choy KT, Yang TWW, Prabhakaran S, Heriot AG, Warrier SK, Kong JC. International Journal of Colorectal Disease 2021 Feb, doi: 10.1007/s00384-021-03849-2 

  64. Retained faecalith following laparoscopic appendectomy. Kim Y, Kong J, Williams E, Warrier S. Clinical Case Report 2021 Jan 27;9(3):1651-1654 (Accepted)

  65. Robotic Colorectal Surgery in Australia: Evolution Over A Decade. Larach JT, Flynn J, Kong J, Paedar WS, McCormick JJ, Declan M, Stevenson A, Warrier SK, Heriot AG. ANZ Journal of Surgery 2021 Jan, doi: 10.1111/ans.16554

  66. A Rare Occurrence of Colonic Cancer Intussusception. Kong JC, Tillman MM. ANZ Journal of Surgery 2021 Jan, doi: 10.1111/ans.16570 

  67. Shifting the treatment paradigm for patients with mismatch repair deficient colon cancer – is there a role for immunotherapy. Kong JC, Flood M, Ramsay R, Warrier SK, Heriot AG. ANZ Journal of Surgery 2020 

  68. The Oncological Reasons for Performing A Complete Mesocolic Excision: A Systematic Review and Meta-analysis. Kong JC, Prabhakaran S, Choy KT, Larach JT, Heriot A, Warrier SK. ANZ Journal of Surgery 2020 Jan;91(1-2):124-131, doi: 10.1111/ans.16518

  69. Anastomosis following low anterior resection – does one size fit all? De Bono JA, Larach JT, Singh P, Kong JC, Smart PJ, Heriot AG, Warrier SK. ANZ Journal of Surgery 2020 

  70. Are we doing enough to assess surgical quality in advanced colon and rectal cancer? Warrier SK, Larach J, Kong JCH, Waters PS, Smart PJ, McCormick JJ, Heriot AG. ANZ Journal of Surgery 2021 Mar;91(3):229-231, doi: 10.1111/ans.16471

  71. The oncological outcomes of transanal total mesorectal excision for rectal cancer in early adopters throughout Australia and New Zealand. Lau S,* Kong JC,* Bell S, Heriot A, Stevenson A, Moloney J, Merrie A, Eglinton T, Guest G, Clark D, Warrier S. British Journal of Surgery 2020 (Accepted) * Co-first authors and have contributed equally to this study

  72. Management of lateral pelvic lymph nodes by Australasian colorectal surgeons – an insight from the west. Cribb B, Kong JC, Warrier S, McCormick J, Heriot A. Asia Pacific Journal of Clinical Oncology 2021 Mar, 10.1111/ajco.13512 

  73. The clinical relevance of circulating tumour DNA in colorectal cancer. Kong JC, Prabhakaran S, Tie J, Ramsay R, Heriot A, Warrier S. ANZ Journal of Surgery 2020 (Accepted)

  74. Robotic abdominoperineal resection, posterior vaginectomy and distal sacrectomy – A video vignette. Rahme J, Rajkomar A, Larach JT, Shayan R, Heriot A, Kong JC, Warrier S. Colorectal Disease 2020 (Accepted)

  75. Non-operative management of small bowel obstruction in a virgin abdomen: A systematic review. TWW Yang, S Prabhakaran, S Bell, M Chin, P Carne, SK Warrier, S Skinner, JC Kong. ANZ Journal of Surgery 2020 Oct, doi: 10.1111/ans.16392

  76. En-bloc resection of locally perforated colonic malignancy with removal of iliopsoas and femoral nerve and primary anastomosis. May J, M Soucisse, JC Kong, Heriot A, Warrier SK. ANZ Journal of Surgery 2020 Sep, doi: 10.1111/ans.16291 

  77. Is it time to deliver additional chemotherapy upfront in our rectal cancer patients? A shifting paradigm. Warrier S, Kong JC, Waters P, McCormick J, Heriot A. ANZ Journal of Surgery 2020 Jan;91(1-2):9-10, doi: 10.1111/ans.16230

  78. Robotic complete mesocolic excision (CME) and central vascular ligation (CVL) for right-sided colon cancer: short-term outcomes from case series. Larach JT, Amrish R, Narasimhan V, Kong JC, Smart PJ, Heriot AG, Warrier SK. ANZ Journal of Surgery 2021 Jan;91(1-2):117-123, doi: 10.1111/ans.16224

  79. Is Laparoscopic Hartmann’s Reversal a Safe Option? A Systematic Review and Meta-analysis. Kong JC, Guerra G, Prabhakaran S, Warrier SK, Heriot AG. World Journal of Colorectal Surgery 2020 

  80. Rate of Anastomotic Leak Following A Right Hemicolectomy by General Surgical Trainees. Ng CW, Prabhakaran S, Chakraborty J, Lutton N, Gourlas P, Gillespie C, Kong JCH. International Journal of Colorectal Disease 2020 Dec;35(12):2339-2346, doi: 10.1007/s00384-020-03730-8

  81. Abdominoperineal Resection in Australasia: Clinical Outcomes, Pedictive Factors, and Recent Trends of Non-Restorative Rectal Cancer Surgery. Smith N, Waters P, Peacock O, Lynch C, McCormick J, Kong JC, Heriot A, Warrier K. Colorectal Disease 2020 Nov;22(11):1614-1625, doi: 10.1111/codi.15263

  82. Utility of intra-operative flexible sigmoidoscopy to assess colorectal anastomosis: A Systematic Review and Meta-analysis. Williams E,* Kong JC,* Prabhakaran, Bell S, Warrier S, Simpson P, Carne P, Farmer C. ANZ Journal of Surgery 2020 Oct, doi: 10.1111/ans.16338 * Co-first authors and have contributed equally to this study

  83. Colorectal Cancer in Younger Adults from a Bi-National Colorectal Cancer Audit Registry. Kong JCH, Ng CW, Su WK, Guerra G, Chakraborty J, Lutton N, Morris B, Gourlas P. ANZ Journal of Surgery 2021 Mar;91(3):367-374, doi: 10.1111/ans.16250

  84. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies. Kong JC, Peacock O, Waters PS, Eglinton T, Warrier SK, Wakeman C, Frizelle FA, Heriot AG, McCormick JJ. Langenbeck’s Archives of Surgery 2020 Jun;405(4):491-502, doi: 10.1007/s00423-020-01895-y

  85. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during the exploration phase. Warrier SK, Bell S, Guest G, Heriot A, Kong JC, Eglinton TW, Hayes J, Merrie A, Clark D, Stevenson A. British Journal of Surgery 2020 Aug;107(9):e353, doi: 10.1002/bjs.11753

  86. Comments on: Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Warrier SK, Bell S, Kong JC, Larach T, Heriot A. British Journal of Surgery 2020 Jun;107(7):e221, doi: 10.1002/bjs.11597

  87. High-dimensional analyses reveal a distinct role of T cell subsets in immune microenvironment of gastric cancer. Wang M, Huang YK, Kong JCH, Xu D, Halse H, Di Costanzo N, Gordon IR, Mitchell C, Mackay LK, Busuttil RA, Neeson PJ, Boussiotas A. Clinical Translational Immunology 2020 May 5;9(5):e1127, doi: 10.1002/cti2.1127

  88. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with HIPEC for isolated colorectal peritoneal metastases: A systematic review and meta-analysis. Narasimhan V, Tan S, Kong J, Pham T, Michael M, Warrier S, Heriot S. Colorectal Disease 2020 Nov;22(11):1482-149

  89. Lateral Pelvic Lymph Node Dissection for Rectal Cancer – Unfinished Business? Cribb B, Kong JC, McCormick J, Warrier S, Heriot A. Australia and New Zealand Journal of Surgery 2020 Jul;90(7-8):1228-1229

  90. Intra-operative Techniques to Assess a Rectal Anastomosis: A Current Perspective. Prabhakaran S, Williams E, Kong J, Warrier S, Farmer K. Australia and New Zealand Journal of Surgery 2020 May;90(5): 655-656

  91. Local Anaesthetic for Haemorrhoidal Rubber Band Ligation Reduces Immediate Post-operative Recovery Time and Use of Opioid Analgesia. Behrenbruch C, Kong J, Chen F. Australia and New Zealand Journal of Surgery 2020 April;90(4): 576-579

  92. Is colonoscopic surveillance necessary after curative resection of colorectal cancer in the elderly patients? Ng SC, Kong JC, Stupart D, Watters DA. World Journal of Colorectal Surgery 2019

  93. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases. Peacock O, Waters PS, Kong JC, Warrier SK, Wakeman C, Eglinton T, Murphy DG, Heriot AG, Frizelle FA, McCormick JJ. Tech Coloproctology 2020 Feb; 24(2):181-190

  94. Pelvic Exenteration for anal and urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years. Smith N, Waters PS, Peacock O, Kong JC, McCormick J, Warrier SK, McNally O, Lynch AC, Heriot AG. Annals of Surgical Oncology 2020 July;27(7):2450-2456

  95. Long-term Outcomes of Locally Advanced Rectal Cancer after Neoadjuvant Chemotherapy: A Bi-national Colorectal Cancer Audit Study. Kong JC, Guerra GR, Lee A, Warrier SK, Lynch AC, Heriot AG. World Journal of Colorectal Surgery 2019

  96. Preoperative management of locally advanced rectal cancer and role of restaging MRI: An Australasian perspective. Mui M, Kong J, Guerra G, Heriot A. World Journal of Colorectal Surgery 9(2), 22-22, 2020

  97. A Unique Case of Lung Cancer Metastasis to a Previous Colonic Anastomosis: A Case Report. Prabhakaran S, Kong JC, Williams E, Warrier S, Farmer C. Australia and New Zealand Journal of Surgery 2020 Jun;90(6): 1186-1188

  98. Complications after extended radical resections for locally advanced and recurrent pelvic malignancies: A 25-year experience. Peacock O, Waters P, Kong J, Eglinton T, Warrier S, Wakaman C, Heriot A, Frizelle F, McCormick J. Annals of Surgical Oncology 2020 Feb; 27(2):409-414

  99. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer. Wang K, Li E, Busuttill R, Kong JC, Pattison S, Sung JJY, Yu J, El-Omar EM, Sumpson JA, Boussioutas A. Therapeutic Advances in Medical Oncology 2020 Jul 23;12:1758835920930359, doi: 10.1177/1758835920930359

  100. Laparoscopic, robotic and transanal reversal of Hartmann’s: pitfalls and challenges. Gosavi R, Kong JCH, Warrier S. Annals of Laparoscopic and Endoscopic Surgery 2019, doi: 10.21037/ales.2019.06.02

  101. Surgical techniques in the management of rectal cancer: a modified Delphi method by colorectal surgeons in Australia and New Zealand. Bell SW, Heriot AG, Warrier SK, Farmer CK, Stevenson ARL, Bissett I, Kong JC, Solomon M. Tech Coloproctology 2019 Aug;23(8):743-749

  102. Appendicorectal fistula with novel solution: First case report and review of literature. McCrystal S, Kong J, Gourlas P, Morris B, Lutton N. Clinical Case Report 2019 Aug 21; 7(10): 1885-1889

  103. Organoids: the new kid in cancer research. Narasimhan V, D Atandrila, Pham T, Willson K, Kong J, Ramsay R, Alexander H. Australia and New Zealand Journal of Surgery 2019, 89(10), 1189-1190

  104. Curative Management of Malignant Left-Sided Colorectal Obstruction - A Review of the Literature. Lee WS,* Kong JC,* Carne P, Bell S, Warrier SK. World Journal of Colorectal Surgery 2019 * Co-first authors and have contributed equally to this study

  105. The Oncological Safety of Laparoscopic versus Open Colorectal Cancer Surgery in the Obesity: A Systematic Review and Meta-analysis. Bell S,* Kong JC,* Carne P, Chin M, Simpson P, Farmer C, Warrier SK. Australia and New Zealand Journal of Surgery 2010, 89(12), 1549-1555 * Co-first authors and have contributed equally to this study

  106. The Safety of Laparoscopic Appendecectomy During Pregnancy: A Systematic Review and Meta-analysis. Chakraborty J,* Kong JC,* Su WK,* Gourlas P, Gillespie C, Slack T, Morris B, Lutton N. Australia and New Zealand Journal of Surgery 2019, 89(11), 1373-1378 * Co-first authors and have contributed equally to this study

  107. Short Term Outcome of Emergency Colorectal Cancer Surgery: Results from Bi-National Colorectal Cancer Audit. Lee CHA, Kong JC, Zalcberg J, Heriot AG, Sitzler P. International Journal of Colorectal Disease 2019 Jan;34(1):63-69

  108. Tumor Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. *Kong JC, *Guerra GR, *Millen R, Roth S, Xu HL, Neeson P, Darcy P, Kershaw M, Sampurno S, Malaterre J, Liu DSH, Pham T, Narasimhan V, Wang M, Huang YK, McCormick J, Lynch C, Warrier SK, Michael M, Desai J, Murray B, Mitchell C, Ngan S, Phillips W, Herior A, Ramsay R. Journal of Clinical Oncology Precision Oncology 2018, doi:10.1200/PO.18.00075 * Co-first authors and have contributed equally to this study

  109. An Update on Immunotherapy for Solid Tumors: A Review. Pham T, Roth S, Kong J, Guerra G, Narasimhan V, Pereira L, Desai J, Heriot A, Ramsay R. Annals of Surgical Oncology 2018 Oct; 25(11): 3404-3412

  110. Wither surgical oncology? Toan DP, Narasimhan V, Guerra G, Kong J, Desai J, Ramsay R, Heriot A. Australia and New Zealand Journal of Surgery 2019 Jan;89(1-2): 10-11

  111. Prognostic Impact of Tumor Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis. Kong JC, Guerra GR, Pham T, Mitchell C, Lynch AC, Warrier SK, Ramsay RG, Heriot AG. Diseases of Colon and Rectum 2019 Apr;62(4): 498-508

  112. The Effect of Increasing Body Mass Index on Laparoscopic Surgery for Colon and Rectal Cancer. Bell S, Kong JC, Wale R, Staples M, Oliva K, Wilkins S, McMurrick P, Warrier SK. Colorectal Disease 2018 Sep; 20(9): 778-788

  113. Prognostic Value of Tumour Regression Grade in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. Kong JC, Guerra GR, Warrier SK, Lynch AC, Michael M, Ngan SY, Phillips W, Ramsay RG, Heriot AG. Colorectal Disease 2018 Jul; 20(7): 574-585

  114. Systematic Review and Meta-analysis of Objective Assessment of Physical Fitness in Patients Undergoing Colorectal Surgery. Lee CHA, Kong J, Bernhard R, Heriot AG. Diseases of Colon and Rectum 2018 Mar; 61(3): 400-409

  115. Salvage Pelvic Surgery for Locoregional Failure in Anal SCC. Guerra GR,* Kong JC,* Bernadi MP, Warrier SK, Ramsay R, Phillips W, Ngan SY, Heriot AG. Diseases of Colon and Rectum 2018 Feb; 61(2): 179-186 * Co-first authors and have contributed equally to this study

  116. Risk Factors Associated with Circumferential Resection Margin Positivity in Rectal Cancer: A Binational Registry Study. Warrier SK,* Kong JC,* Guerra GR, Chittleborough TJ, Naik A, Ramsay RG, Lynch AC, Heriot AG. Diseases of Colon and Rectum 2018 Apr; 61(4): 433-440 * Co-first authors and have contributed equally to this study

  117. Colonoscopic Surveillance: Quality, Guidelines and Effectiveness. Chittleborough TJ, Kong JC, Guerra GR, Ramsay R, Heriot AG. ANZ Journal of Surgery 2018 Jan;88(1-2):32-38

  118. An Electronic Web-based Colonoscopy Guidelines: Ease of Use and Improvement in Compliance. Kong JC, Low D, Wardill D, Stupart D, Guest G, Watters D. World Journal of Colorectal Surgery 2017

  119. Delivery of humidified-warm carbon dioxide during open abdominal surgery in murine model reduces cellular injury but does not decrease peritoneal tumourigenesis to damaged sites. Carpiteri S, Sampurno S, Malaterre J, Millen R, Dean M, Kong J, Chittleborough T,  Heriot A, Lynch AC, Ramsay RG. British Journal of Surgery 2017 Nov 28; 105:597-605

  120. External Validation of VGSSI and ATLAS Scores and the Identification of Risk Factors Associated with Mortality in Clostridium difficile Infections. Figh ML, Zoog ESL, Moore RA, Dart BW, Heath G, Butler R, Gao L, Kong JC, Stanley JD. The American Journal of Surgery 2017 Dec 1;83(12):1347-1351

  121. Outcome and Salvage Surgery Following “Watch and Wait” for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review. Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG. Diseases of Colon and Rectum 2017 Mar; 60(3):335-345

  122. Primary squamous cell carcinoma of the rectum: An update and implications for treatment. Guerra GR, Kong CH, Warrier SK, Lynch AC, Heriot AG, Ngan SY. World Journal Gastrointestinal Surgery 2016 March 27;8(3):252-65

  123. Colorectal preOperative Surgical Score (CrOSS) for mortality in major colorectal surgery. Kong CH, Guest GD, Stupart DA, Faragher IG, Chan ST, Watters DA. ANZ Journal of Surgery 2015 Jun;85(6):403-7

  124. A case of a bleeding benign gastrocolic fistula in 2014. Winata LS, Kong CH, Thiruchelvam D. International Journal of Surgery Case Report 2014; 5(12):948-50

  125. Recalibration and validation of a preoperative risk prediction model for mortality in major colorectal surgery. Kong CH, Guest GD, Stupart DA, Faragher IG, Chan ST, Watters DA. Diseases of Colon and Rectum. 2013 Jul;56(7):844-9. 

Research: Text

Prizes

Finalist in the Category of – Improving Healthcare Through Clinical Research

Victorian Public Healthcare Awards, Melbourne, Victoria, Australia, Nov 2019


CSSANZ Foundation Award for ANZTBRCS Fellow’s Research from a Higher Degree

Australia and New Zealand Training Board for Colon and Rectal Surgery (ANZTBCRS) Trainee Weekend, Hobart, Tasmania, Aug 2019

​

RJS Translational Research Prize

Division of Cancer Surgery and Anaesthetics Annual Research Day, Melbourne, Victoria, Dec 2017


Best Poster Session presented by Ms. Madhyra Tri Indraswari

Ingraswari MT, Kong JCH, Heriot AG

Brazilian International Congress of Medical Student, Sao Paulo, Brazil, Sep 2017


Mark Killingback Prize for best colorectal research paper

Royal Australasian College of Surgeons Annual Scientific Congress, Adelaide, Australia, May 2017


Young Investigator Award for best scientific research paper

Research Surgical Society, Section of Academic Surgery, Melbourne, Australia, Nov 2016


Best research paper for Quality Assurance and Audit Forum

Low D, Wardill D, Guest G, Stupart D, Watters D

Royal Australasian College of Surgeons Annual Scientific Congress, Auckland, New Zealand, May 2013


Mark Killingback Prize for best colorectal research paper

Royal Australasian College of Surgeons Annual Scientific Congress, Kuala Lumpur, Malaysia May 2012


Second Prize for best HMO research at Barwon Health HMO research prize

Geelong, Victoria, Australia, October 2011


John Ham Prize for best research paper

General Surgeons Australia Annual Scientific Meeting, Darwin, Northern Territory, Australia, September 2011

Awards

Grants

​

Merck Clinical Trials in 2017

Phase I/II trial PD-L1/PD-1 blockade Avelumab (MSB0010718C) with Chemoradiotherapy for Locally Advanced Resectable T3-4/N1-2 Rectal Cancer

​

CSSANZ Foundation Grant in 2016

Immune Markers to Predict Response and Investigating the Role of Immunotherapy in Neoadjuvant Rectal Cancer Treatment

​

Scholarships

NHMRC Post Graduate Scholarship 

By NHMRC from 2017 and 2018


Paul MacKay Bolton Scholarship for Cancer Research

By Royal Australasian College of Surgeons from 2017 and 2018


Foundation of Surgery John Loewenthal Research Scholarship

By Royal Australasian College of Surgeons in 2016


Raelene Boyle Research Scholarship (Sporting Chance Cancer Foundation)

By Royal Australasian College of Surgeons in 2015

Research Fellowships

Discovery Partner Research Fellowship

$75,000 per annum for 5 years

Peter MacCallum Cancer Centre

​

Foundation for Surgery Research Fellowship

$66,000 per annum for 3 years

Royal Australasian College of Surgeons

IMG_9262.JPG

Contact Us

Dr Joseph Kong is currently consulting at

Peter MacCallum Cancer Centre (public)

Alfred Health (public)

Cabrini Hospital - Malvern (private)

Cabrini Hospital - Brighton (private)

Cabrini Specialist Centre - Hawthorn East (private)

The Avenue Hospital (private)

​

Dr Joseph Kong has operating list at

Peter MacCallum Cancer Centre (public)

Alfred Health (public)

Cabrini Hospital - Malvern (private)

Cabrini Hospital - Brighton (private)

The Avenue Hospital (private)

Colorectal Consulting Group (CCG)

Specialist in Colorectal Surgery

Cabrini Hospital - Malvern

Suite 27, Cabrini Medical Centre,

Isabella Street,

Malvern 3144

​

Opening Hours: 9.00 am to 5.00 pm - Monday to Friday

Email: jkongpa@ccgroup.net.au

Phone: 03 9500 2795

After hours: 03 9387 1000

Fax: 03 9576 0318

Thanks for submitting!

©2021 by Joseph Cherng Kong. Proudly created with Wix.com

bottom of page